Quick10K

⚲

Medidata

Filings

10-Q	2019-06-30	Filed 2019-08-06
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-01
10-Q	2018-09-30	Filed 2018-10-30
10-Q	2018-06-30	Filed 2018-08-02
10-Q	2018-03-31	Filed 2018-05-04
10-K	2017-12-31	Filed 2018-02-28
10-Q	2017-09-30	Filed 2017-11-03
10-Q	2017-06-30	Filed 2017-08-01
10-Q	2017-03-31	Filed 2017-05-08
10-K	2016-12-31	Filed 2017-02-28
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-05
10-Q	2016-03-31	Filed 2016-05-09
10-K	2015-12-31	Filed 2016-02-29
10-Q	2015-09-30	Filed 2015-11-05
10-Q	2015-06-30	Filed 2015-08-10
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-02
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-04-30
10-K	2013-12-31	Filed 2014-02-25
10-Q	2013-09-30	Filed 2013-11-04
10-Q	2013-06-30	Filed 2013-08-02
10-Q	2013-03-31	Filed 2013-05-03
10-K	2012-12-31	Filed 2013-03-08
10-Q	2012-09-30	Filed 2012-11-09
10-Q	2012-06-30	Filed 2012-08-07
10-Q	2012-03-31	Filed 2012-05-04
10-K	2011-12-31	Filed 2012-03-13
10-Q	2011-09-30	Filed 2011-11-08
10-Q	2011-06-30	Filed 2011-08-09
10-Q	2011-03-31	Filed 2011-05-10
10-K	2010-12-31	Filed 2011-03-16
10-Q	2010-09-30	Filed 2010-11-10
10-Q	2010-06-30	Filed 2010-08-13
10-Q	2010-03-31	Filed 2010-05-14
10-K	2009-12-31	Filed 2010-03-15

Reports

8-K	2019-10-28	Leave Agreement, M&A, Shareholder Rights, Control, Officers, Amend Bylaw, Exhibits
8-K	2019-09-23	Other Events, Exhibits
8-K	2019-08-16	Shareholder Vote, Other Events, Exhibits
8-K	2019-07-23	Earnings, Exhibits
8-K	2019-06-12	Other Events, Exhibits
8-K	2019-06-11	Enter Agreement, Officers, Amend Bylaw, Exhibits
8-K	2019-05-29	Shareholder Vote
8-K	2019-04-30	Earnings, Exhibits
8-K	2019-04-15	Amend Bylaw, Exhibits
8-K	2019-02-12	Earnings, Exhibits
8-K	2019-02-12	Officers
8-K	2018-10-19	Officers, Regulation FD, Exhibits
8-K	2018-10-18	Earnings, Exhibits
8-K	2018-08-01	Sale of Shares
8-K	2018-07-24	Earnings, Exhibits
8-K	2018-06-20	M&A, Exhibits
8-K	2018-06-11	Enter Agreement, Exhibits
8-K	2018-05-30	Shareholder Vote
8-K	2018-04-19	Earnings, Exhibits
8-K	2018-02-20	Officers
8-K	2018-02-08	Earnings, Exhibits

Medidata Financials

MDSO Metrics, Comps, Filings

Quarterly | Annual

Business

Medidata is a global life sciences technology provider, dedicated to improving the way clinical research is designed, conducted, analyzed, and commercialized. Our cloud-based platform of solutions, data analytics, and AI enables efficiency and improves quality throughout clinical development programs by accelerating processes, enhancing decision-making, minimizing operational risk, reducing costs, and transforming trial strategies.

Customers can utilize our entire platform or individual solutions, and can subscribe to our technology on a multi-study or single-study basis. Our revenue is comprised of subscription and professional services, which represent approximately 85% and 15% of our business, respectively. Our subscription business model provides us with a recurring revenue stream that we believe delivers greater revenue visibility than perpetual software licensing models.

The Medidata Cloud is the Intelligent Platform for Life Sciences, transforming clinical development and converting complex data into cutting-edge insights. It provides a unified platform for demonstrating treatment efficacy and safety, supporting regulatory approval, achieving peak revenue faster, improving outcomes for patients, providers, and payers, and paving the way for the increasingly more precise therapies of the future.

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Ceridian (CDAY)	7,310	45%	75.7	1%	5,436	3,583	602	270	80	92	6,953
Anaplan (PLAN)	6,867	73%	-65.5	-18%	618	324	250	183	-113	-100	6,556
Elastic (ESTC)	6,666	71%	-45.0	-19%	767	334	342	243	-148	-141	6,359
MongoDB (MDB)	6,619	70%	-71.3	-15%	735	516	298	208	-113	-91	6,467
Hubspot (HUBS)	6,559	81%	-293.8	-4%	1,479	851	633	511	-55	-22	6,325
RealPage (RP)	6,189	75%	43.8	2%	2,292	1,143	733	548	44	138	6,060
Avalara (AVLR)	6,080	70%	-250.8	-5%	725	261	275	192	-35	-22	5,633
SolarWinds (SWI)	5,945	72%	38.0	-0%	5,156	2,563	906	654	-9	202	7,679
Medidata (MDSO)	5,643	74%	78.2	4%	1,024	363	685	504	44	70	5,497
National Instruments (NATI)	5,573	75%	29.6	6%	1,628	466	986	740	104	181	5,351
Manhattan Associates (MANH)	5,367	41%	39.7	25%	380	229	609	252	95	132	5,254
Paylocity Holding (PCTY)	5,300	67%	42.0	4%	1,598	1,289	494	333	58	99	4,164
Nutanix (NTNX)	4,920	76%	-7.3	-41%	1,866	1,803	1,238	935	-756	-640	4,683
Nuance Communications (NUAN)	4,785	57%	13.3	4%	5,366	3,193	1,823	1,043	214	480	6,368
Smartsheet (SMAR)	4,461	81%	-67.9	-9%	775	248	192	155	-68	-58	3,946
Blackbaud (BLKB)	4,435	54%	46.0	1%	1,710	1,329	884	479	20	101	4,668
Pivotal Software (PVTL)	4,133	68%	-42.0	-5%	1,939	575	577	395	-93	-79	3,311
Sina (SINA)	3,884			0%	5,886	2,123	0	0	0	0	2,241
ACI Worldwide (ACIW)	3,810	53%	16.7	3%	3,341	2,282	1,178	630	99	307	5,119


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Cash	22	26	45	58	59	37	33	37	39	192	22	25	35	27	40	71	43	63	50	88	64	65	94	90	116	134	243	232	126	89	113	116	146
Accounts Receivable	28	19	23	31	36	32	42	48	42	41	46	66	62	51	68	80	94	87	91	78	90	115	115	102	111	106	111	133	137	163	171	178	198
Inventory
PP&E	9	9	10	9	9	9	42	11	14	24	67	40	41	40	71	40	42	44	92	52	55	54	105	63	71	82	151	93	93	97	189	111	114
Assets	159	166	190	201	209	212	225	230	241	546	573	561	571	587	622	644	672	684	687	674	712	786	818	827	889	914	1,046	1,076	1,103	868	913	997	1,024
Accounts Payable	1	2	4	2	2	4	3	1	2	4	8	6	5	4	4	6	3	2	6	2	1	1	6	7	12	2	5	8	7	7	7	8	11
Long-Term Debt										288	288	288	288	288	288	288	288	288	288	288	288	288	288	288	288	288
Liabilities	90	87	86	87	90	83	83	76	80	331	348	336	337	338	358	373	384	382	403	380	397	407	416	416	446	446	549	554	541	274	282	360	363
Stockholders' Equity	68	79	104	114	119	129	142	154	161	215	226	225	234	249	265	271	288	302	284	294	315	379	402	411	443	468	497	522	561	594	631	637	660


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Revenue	50	46	47	50	54	56	59	63	75	71	75	77	89	86	89	92	98	103	99	104	115	120	124	127	137	140	141	149	156	163	167	174	180
Cost of Revenue	13	14	13	15	17	16	16	17	18	17	19	21	21	21	22	22	23	23	22	25	29	29	30	31	32	32	33	36	38	42	43	46	50
Gross Profit	37	33	34	36	41	40	42	46	51	54	56	56	64	65	67	70	75	80	77	80	86	91	95	96	105	109	109	113	118	121	124	128	131
R&D
SG&A	19	18	19	20	23	22	23	27	30	31	43	38	38	39	38	45	48	45	44	45	46	48	49	54	56	55	56	62	65	66		76	80
Tax		0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	3	-0	1	3	4	3	1	2	6	1	1	1	2		-6	-6
Net Income	10	7	19	4	4	4	7	6	7	5	1	-2	2	0	5	0	2	5	7	6	5	7	11	10	8	13	14	10	17	11	14	11	8


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Cash Operating		15	2	3	6	8	-3	3	26	20	20	-6	24	22	21	17	12	28	31	12	26	10	40	22	38	31	30	5	19	33		6	24
Cash Investing		-11	12	7	-4	-32	-6	0	-19	-151	-192	27	-11	-38	-9	19	-39	-7	-10	33	-53	-8	-13	-17	-26	-15	-20	-5	-125	213		20	16
Cash Financing		0	4	3	-1	2	5	2	-5	284	2	-18	-4	7	1	-4	-1	-1	-35	-7	4	-1	2	-9	7	2	99	-11	0	-283		-22	-10